Thrombotic complications of atherosclerotic vascular disease are mediated by both platelet-dependent mechanisms and tissue factor-mediated activation of the coagulation system. Platelet-rich thrombosis in response to atherosclerotic plaque rupture is a critical determinant of the clinical manifestations of atherosclerotic vascular disease (e.g., unstable angina, myocardial infarction) and the vascular wall response to injury (e.g., intimal hyperplasia). The central hypothesis of this proposal is that thrombus-associated procoagulants, primarily thrombin bound to fibrin and factor Xa/Va complex bound to phospholipids, are critical determinants of the progression of thrombosis and designed to characterize molecular mechanisms responsible for thrombus-associated procoagulant activity, and to define the extent to which attenuation or potentiation of clot-associated procoagulant activity in vivo influences the progression of thrombosis and the response to antithrombotic interventions. To accomplish these objectives, the molecular determinants of thrombus-associated procoagulant activity will be defined, including mechanisms involved in the binding of thrombin and Xa/Va to whole blood thrombi, determinants of the activity of thrombus- associated factor Xa/Va, and the interactions between thrombus-associated thrombin, Xa/Va, and the platelets in the regulation of local thrombin activity.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL054255-03
Application #
2771419
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1996-09-30
Project End
2000-08-31
Budget Start
1998-09-01
Budget End
2000-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Abendschein, D R; Yang, L Y; Chun, J et al. (2003) Prolonged procoagulant activity on overstretch-injured coronary arteries in pigs. J Thromb Haemost 1:836-42
Abendschein, D R; Baum, P K; Verhallen, P et al. (2001) A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs. J Pharmacol Exp Ther 296:567-72
Eisenberg, P R; Ghigliotti, G (1999) Platelet-dependent and procoagulant mechanisms in arterial thrombosis. Int J Cardiol 68 Suppl 1:S3-10
Ghigliotti, G; Waissbluth, A R; Speidel, C et al. (1998) Prolonged activation of prothrombin on the vascular wall after arterial injury. Arterioscler Thromb Vasc Biol 18:250-7